v3.26.1
Condensed Balance Sheets - USD ($)
Apr. 30, 2026
Oct. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 6,848,064 $ 4,808,965
Restricted cash 453,974 25,155
Share subscription receivable 0 2,000,000
Tax receivable 0 3,037
Interest receivable 2,171 0
Convertible note receivable 0 71,326
Prepaid expenses 609,476 549,930
TOTAL CURRENT ASSETS 7,913,685 7,458,413
NON-CURRENT ASSETS    
Deferred offering costs 0 42,177
Investment, at cost 71,328 0
Security deposit 12,317 0
Fixed assets, net of accumulated depreciation of $10,712 and $7,431, respectively 38,400 11,237
Patent, net of accumulated amortization of $22,754 and $9,819, respectively 163,949 176,884
TOTAL ASSETS 8,199,679 7,688,711
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 455,055 256,296
Accounts payable and accrued liabilities - related parties 71,309 0
Wages payable 0 76,000
Shares to be issued under the warrant inducement program 427,967 0
Warrants to be issued under the warrant inducement program 543 0
Liabilities to be settled with shares 44,700 0
Due to shareholders 3,722 3,722
TOTAL LIABILITIES 1,003,296 336,018
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 50,000,000 shares authorized, 0 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively 0 0
Common Stock, par value $0.001, 250,000,000 shares authorized, 20,916,173 and 18,906,066 shares issued and outstanding as of April 30, 2026 and October 31, 2025, respectively 20,916 18,906
Additional paid-in capital 15,720,093 11,855,307
Accumulated deficit (8,544,626) (4,521,520)
TOTAL SHAREHOLDERS' EQUITY 7,196,383 7,352,693
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 8,199,679 $ 7,688,711

Source

10-Q XBRL Zip